With the American Association for Cancer Research’s annual conference now underway, oncology researchers can expect ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

Presentations at this year’s American Association for Cancer Research meeting could have a broad impact on the treatment ...

Company prepares new product launches starting in 2025.

Boehringer Ingelheim and Tessellate Bio have entered into a partnership worth over €500m to develop oral precision medicines ...

IT can’t sit back - the company’s 2,000 technology professionals must drive the identification of digital solutions to ...

Ingelheim: Boehringer Ingelheim and Tessellate Bio, a precision oncology company, have entered into a research collaboration ...

Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality ...

The "Enterprise Tech Ecosystem Series: Boehringer Ingelheim 2025" company profile has been added to ResearchAndMarkets.com's offering. Boehringer Ingelheim International: Leading the Way in ...

Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, development, and manufacturing.